Middle
NIAID Releases Strategic Plan for Tuberculosis Research
TB is the world’s leading infectious cause of death. In its new strategic plan, NIAID details five strategic priorities for building on research advances to develop the knowledge and tools to end TB globally.
Middle
Ebola Treatment Trial Begins in the DRC
A randomized, controlled Phase 2/3 trial testing multiple investigational Ebola therapies is enrolling patients with Ebola in the Democratic Republic of the Congo.
Middle
World AIDS Day 2018
Each year on World AIDS Day, we reflect on the remarkable progress that has been made against HIV. Indeed, we have come a long way since the disease now known as AIDS was first reported in 1981.